EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting resident astrocytes attenuates neuropathic pain after spinal cord injury

Qing Zhao, Yanjing Zhu, Yilong Ren, Lijuan Zhao, Jingwei Zhao, Shuai Yin, Haofei Ni, Rongrong Zhu, Liming Cheng, Ning Xie

eLife · 15.11.2024 · 13

DOI: 10.7554/elife.95672.3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, online erschienen am 15.11.2024. Verfasst von Qing Zhao und 9 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: International cooperation project of National Natural Science Foundation of China, Natural Science Foundation of China, National Key R&D Program of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Astrocytes derive from different lineages and play a critical role in neuropathic pain after spinal cord injury (SCI). Whether selectively eliminating these main origins of astrocytes in lumbar enlargement could attenuate SCI-induced neuropathic pain remains unclear. Through transgenic mice injected with an adeno-associated virus vector and diphtheria toxin, astrocytes in lumbar enlargement were lineage traced, targeted, and selectively eliminated. Pain-related behaviors were measured with an electronic von Frey apparatus and a cold/hot plate after SCI. RNA sequencing, bioinformatics analysis, molecular experiment, and immunohistochemistry were used to explore the potential mechanisms after astrocyte elimination. Lineage tracing revealed that the resident astrocytes but not ependymal cells were the main origins of astrocytes-induced neuropathic pain. SCI-induced mice to obtain significant pain symptoms and astrocyte activation in lumbar enlargement. Selective resident astrocyte elimination in lumbar enlargement could attenuate neuropathic pain and activate microglia. Interestingly, the type I interferons (IFNs) signal was significantly activated after astrocytes elimination, and the most activated Gene Ontology terms and pathways were associated with the type I IFNs signal which was mainly activated in microglia and further verified in vitro and in vivo. Furthermore, different concentrations of interferon and Stimulator of interferon genes (STING) agonist could activate the type I IFNs signal in microglia. These results elucidate that selectively eliminating resident astrocytes attenuated neuropathic pain associated with type I IFNs signal activation in microglia. Targeting type I IFNs signals is proven to be an effective strategy for neuropathic pain treatment after SCI.

Förderung

  • International cooperation project of National Natural Science Foundation of China
  • Natural Science Foundation of China
  • National Key R&D Program of China
  • Shanghai Rising-Star Program
  • Fundamental Research Funds for the Central Universities
  • Programs in Emergency and Critical Care Medicine, Shanghai Municipal Health Commission
  • National Key Specialty Program, National Health Commission of China

Zitieren

APA

Zhao, Q., Zhu, Y., Ren, Y., Zhao, L., Zhao, J., Yin, S., Ni, H., Zhu, R., Cheng, L., & Xie, N. (2024). Targeting resident astrocytes attenuates neuropathic pain after spinal cord injury. eLife, 13. https://doi.org/10.7554/elife.95672.3

Vancouver

Zhao Q, Zhu Y, Ren Y, Zhao L, Zhao J, Yin S, et al. Targeting resident astrocytes attenuates neuropathic pain after spinal cord injury. eLife. 2024;13. doi:10.7554/elife.95672.3

BibTeX
@article{Zhao2024,
  author = {Zhao, Qing and Zhu, Yanjing and Ren, Yilong and Zhao, Lijuan and Zhao, Jingwei and Yin, Shuai and Ni, Haofei and Zhu, Rongrong and Cheng, Liming and Xie, Ning},
  title = {Targeting resident astrocytes attenuates neuropathic pain after spinal cord injury},
  journal = {eLife},
  year = {2024},
  volume = {13},
  doi = {10.7554/elife.95672.3}
}
Kostenlos starten →